Homepage Featured News
July 20, 2021
Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic
Selected Recipients of the New “Back to Screening Award for Research Advocacy Excellence” will be Honored at Fight Colorectal Cancer’s “Path to a Cure” Event in December 2021
November 18, 2021
Guardant Health Reports Third Quarter 2021 Financial Results
Achieved record revenue of $94.8 million, Growth of 35% and 58% year over year in clinical and biopharma volumes, respectively